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Abstract
We grouped as oral lichenoid disease (OLD) a series of chronic inflammatory processes with autoimmune base 
that affect the epithelium of the oral mucosa. This disease is present in 2% of the population with a marked predi-
lection for the female gender, especially perimenopausal women. Clinically, it is characterized by the presence of 
lineal reticular papules and histologically by liquefaction degeneration of the basal layer of the epithelium asso-
ciated with an inflammatory infiltrate with a “band-like” disposition on the lamina propria, composed primarily 
of T lymphocyte cells. Its pathogenicity is associated with deregulation of the cellular immune system, where the 
activated cytotoxic CD8 and the CD4 T helper lymphocytes induce apoptosis of the epithelial cells. Classically it 
has been considered a precancerous condition, although the malignant transformation does not exceed 1% of the 
cases. In recent years the differentiation between oral lichen planus (OLP) and oral lichenoid lesions (OLL) has 
become important, since the latter might have a greater malignant potential. In this paper, we analyse and update 
some controversial aspects of this frequent oral disease in relation to the diagnosis and malignant potential.
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Introduction
Classically “oral lichen planus” (OLP) has always been 
considered a chronic inflammatory mucous process of 
autoimmune origin that affects primarily perimeno-
pausal women (1-3). Recently, we have proposed a new 
nomenclature and classification for these processes that 
we denominate generically as “oral lichenoid disease” 
(OLD) (4).
The basic clinical lesion that groups these processes is 
the white lineal papule that reveals a reticular pattern, 
generally asymptomatic (Fig.1) (2,5). The most frequent 
sites are the buccal mucosa, tongue, gingiva and lips, 
with a bilateral and symmetrical pattern characteristic 
of typical cases (1,2). The etiology of the majority of 
these processes is unknown, although there is general 
agreement in considering it an autoimmune process 
in which cytotoxic CD8 T  lymphocytes (CD8TL) and 
CD4 T lymphocytes (CD4TL) participate, accumulate 
and are activated by different mechanisms inducing 
cellular apoptosis, degeneration of the basal layer and 
destruction of the epithelial basal membrane (2,6-8). 
There are other processes similar to OLP that do not 
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gather the entire typical clinicopathological require-
ments and are denominated as “oral lichenoid lesions” 
(OLL) (9). These OLL can be reactive when there is a 
known cause (i.e. related to an amalgam restoration), or 
idiopathic (4). The OLL have been the object of special 
interest due, apparently, to a greater risk of malignant 
transformation than the classic OLP (3,10-12). Without 
any doubt, the most important complication of the pro-
cesses grouped as OLD, is its possible malignant trans-
formation (2,12-18). 
In this paper we carry out a review and update of some 
controversial aspects of these processes, related to etio-
pathogenicity, as well as the diagnosis and prognosis.
Etiopathogenical Aspects
Although the exact etiology of OLP is unknown in the 
majority of the cases, it is considered as a multifactorial 
process related to many factors such as genetic influen-
ce, and psychological or infectious conditions, among 
others. Some of these factors would act as causal agents 
long before others that would be precipitant of the pro-
cesses (2,6,15). 
Nowadays, it is considered an autoimmune disease by 
which the cytotoxic CD8TL are attracted and activated 
by one or more antigens associated to a major histocom-
patibility complex class I (MHC-I) expressed by kera-
tinocytes, together with helper CD4TLs, that would be 
attracted and activated by the major histocompatibility 
complex class II (MHC-II)  associated with Langerhans 
cells (Lc) and/or keratinocytes (6). In these cases, di-
fferent cytokines (IL-2, IL-12), gamma interferon (IFN-
gamma) and the tumor necrosis factor-alpha (TNF-
alpha), participate being secreted by the different cellu-
lar elements involved. The TNF-alpha secreted by the 
cytotoxic CD8TL cause apoptosis of the keratinocytes 
and stimulate an over-expression of the adhesion mole-
cules (ELAM-I, ICAM-I, VCAM-I) by the endothelial 
cells of the subepithelial vascular plexus that participate 
in the inflammatory process in an important way (2,6).
The chronic character of this inflammatory process 
can be explained by two ways of tissue damage (7,8). 
The first way would be by an antigen-specific mecha-
nism where the basal keratinocytes and the Lc would 
present antigens associated with CMH-I and CMH-II. 
The CMH-I antigens stimulate the cytotoxic CD8TL to 
secrete TNF-alpha and the CMH-II antigens stimulate 
the CD4TL to secrete IL-2 and gamma-IFN, that would 
cause continuous damage to the keratinocytes (6-8). 
The second way would be by non-specific mechanisms 
that cause degranulation of the mastocytes and a poste-
rior activation of metalloproteinases (MMP), which de-
grade components of the extracellular matrix and basal 
membrane (7,19). 
It has been pointed out that more than 60% of the 
mastocytes of the OLP lesions are degranulated when 
compared with the non-affected mucosa (6,20). The de-
granulation of the mastocytes is an important source of 
chymase and tryptase, which are MMP 1, 3 and 9 ac-
tivator proteases (19). Also mediators liberated by the 
mastocytes participate in the migration of lymphocytes 
through the epithelium (6). 
Specifically, TNF-alpha stimulates the over-expres-
sion of some adhesion molecules (CD62E, CD54, and 
CD106), necessary for the adhesion of the lymphocytes 
to the vascular wall for its posterior extravasation (19). 
MMP-9, from T lymphocytes, is activated by chymase 
and tryptase, and cause damage to the type IV collagen 
and the basal membrane (6,19).
Fig. 2. Hyperorthokeratosis, granulosis, epithelial atrophy, asso-
ciated with a band-like lymphocyte inflammatory infiltrate of the 
lamina propria, are classical histopathological data of the lichenoid 
disease (H&E 20x). 
Fig. 1. White reticular papules in buccal mucosa with an erosive-
ulcerative central area in a typical case of oral lichenoid disease.
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Histopathological Aspects
Classic OLP is histopathologically characterized by the 
presence of hyperkeratosis and/or atrophy, hydropic de-
generation of the basal layer, apoptotic keratinocytes 
(Civatte bodies) and a “band-like” chronic inflamma-
tory infiltrate in the lamina propria constituted prima-
rily by T lymphocyte cells (Fig.2) (8). Nevertheless, this 
histological aspect is not pathognomonic for OLP as can 
be observed in other chronic mucocutaneous processes 
(11). 
OLLs are hard to define entities and differentiate from 
OLP by revealing similar clinical and histopathological 
characteristics. For this reason, it is essential to make 
a detailed clinical examination, since histopathological 
diagnostic errors may be associated with the omission 
of clinical data (11). In 2003, Van der Meij, et al. (9) des-
cribed a series of clinical and histopathological criteria 
typical for OLP (Table 1), to be considered as “clinica-
lly and histopathologically compatible with OLP”. Fo-
llowing these criteria, we should denominate OLL for 
all those atypical clinical situations. Characteristically, 
OLLs are unilateral, near dental restorations or associa-
ted with drugs (3,4). 
Some authors (11) point out, that it is almost impossible 
to differentiate between OLP and OLL only by using 
histopathological data. Nevertheless, there are other su-
ggestive characteristics, such as, a deeper inflammatory 
infiltrate from the lamina propria to the submucosa, in 
some areas or in the totality of the sample, or the exis-
tence of perivascular inflammation with plasmatic cells 
and neutrophils, which are absent in OLP. It is impor-
tant to rule out the presence of Candida and to avoid 
ulcerated areas that could lead to a misdiagnosis by in-
ducing secondary accumulation of plasmatic cells and 
neutrophils (11).
In recent years, many studies based on immunohisto-
chemistry have tried to differentiate and to predict the 
malignant potential of these processes, obtaining a si-
milar expression of ki67 on OLP and OLL, and a greater 
expression of p53 on OLP lesions (10,21). 
The lichenoid lesions that present epithelial dysplasia on 
the biopsies should be treated as any other oral dysplas-
tic lesion, and should be excluded from the diagnosis of 
OLP or OLL, as well as for the equivocal diagnosis of 
“lichenoid dysplasia” (9).
Pronostical Aspects
The most important complication of all these proces-
ses is the possible malignant transformation, reason for 
which it has been considered a precancerous condition 
(2,3,21). Many series of cases have been published in 
relation to the malignant transformation in this contro-
versial pathology (5,12,14,16,18,22). Although the ma-
lignant transformation rate varies widely in the literatu-
re from 0.4 to 6.5%, in most studies it does not exceed 
1% (2,5,16).
In the review made by Lodi, et al. (5) that gathered stu-
dies published between 1985 and 2004, with a follow-up 
of 4.5 to 7.5 years, they observed a malignant transfor-
mation rate between 0 and 5.3%.   
Clinical criteria*:
Presence of bilateral symmetrical lesions.•	
Presence of white-grey lineal reticular papules (reticular pattern).•	
Erosive-ulcerative, atrophic, bullous and plaque-like lesions (accepted only in the •	
presence of reticular papular lesions in any location of the mucosa).
Histopathological criteria †:
Presence of a well-defined “band-like” cellular infiltrate, confined to the superficial •	
portion of the connective tissue and composed primarily of lymphocytes. 
Signs of “liquefactive degeneration” of the epithelial basal cell layer. •	
Absence of epithelial dysplasia.•	
Final diagnosis:
The clinical and histopathological criteria should be included for a final diagnosis.•	
OLP diagnosis should include both criteria, clinical and histopathological.•	
LLO diagnosis should be used when:•	
                                                          1. Clinically typical for OLP but histologically compatible with OLP.  
                                                          2. Histologically typical for OLP but clinically compatible with OLP.
                                                          3. Clinically and histopathologically compatible with OLP.
Table 1. Diagnostic criteria for oral lichen planus (OLP) and oral lichenoid  lesions (OLL). Modified by (Van der Meij E, 
et al. J Oral Pathol Med. 2003;32:507-12).
WHO, World Health Organization; OLP: Oral Lichen Planus; OLL: Oral Lichenoid Lesion
* In other lesions similar to OLP, but that do not completely fit the criteria, should be used “clinically compatible with”.
† When the histopathological characteristics are less obvious, should be used “histologically compatible with”.
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Classically a greater risk has been described for malig-
nant transformation of the “atypical” clinical presenta-
tion, specially the atrophic and erosive-ulcerative types 
(16,23). Eisen (15), found that the 6 (0.8%) patients who 
developed a malignant transformation had atrophic-
erosive lesions. This circumstance could be related to 
a greater chronic inflammatory response, behaving si-
milarly to other inflammatory diseases also associated 
with neoplastic malignant growth, such as inflamma-
tory intestinal disease, chronic esophagitis or chronic 
colicystitis (7,24,25). Chronic inflammation would play 
an important role in the possible carcinogenesis of this 
process, causing genetic damage and inducing tissular 
proliferation (26). The increase of cytokines and growth 
factors, promote and/or facilitate oral carcinogenesis 
(7,25,26). Chronic inflammation produces oxidative 
damage of the DNA by products derived from inflam-
matory induced enzymes, such as nitric oxide synthase 
(iNOS) (27). 
Another inducible inflammation enzyme is cicloxige-
nase-2 (COX-2) that acts inhibiting apoptosis of the ke-
ratinocytes and in so doing, facilitating carcinogenesis 
(28). 
In recent years, the process of malignant transformation 
of the lichenoid lesions has been related to a possible 
“field cancerization” phenomena, by which all associa-
ted events would predispose these patients to a greater 
risk of multiple and/or multifocal neoplastic malignan-
cies in the oral cavity (25).
One of the major problems of interpretation of malig-
nant potential studies of this disease is the inexisten-
ce of strict diagnostic criteria to differentiate lichenoid 
processes (9). Some studies have included cases of OLP 
with OLL and vice versa. For this reason it is funda-
mental to establish precise clinical and histopathologi-
cal diagnostic criteria to differentiate the lesions and 
in this way to assess the real malignant potential (4,9). 
A Holland group (14), studied 67 patients with OLP 
and 125 with OLL, using previous diagnostic criteria 
to differentiate them from one another, and an average 
follow-up of 55.9 months, finding a malignant transfor-
mation in 4 patients (2.1%), all diagnosed as OLL. Pre-
viously, this group (12) obtained similar results, having 
3 patients (1.7%) with malignant transformation of the 
lesions, all of them diagnosed as OLL. These studies 
would confirm the existence of a greater risk of malig-
nant transformation of “atypical lesions” diagnosed as 
OLL, which would support the need to always make a 
careful clinical and histopathological diagnostic sepa-
ration (4).
There are no definitive and reliable criteria that would 
allow us to determine which patients present a greater 
risk of malignant transformation. For this reason, a clini-
cal surveillance protocol would be of great importance. 
Therefore, Mignogna et al. (18) applied a surveillance 
protocol with periodic examinations every 4 months for 
12 years, denominated “Neoplasia/Dysplasia” in 45 pa-
tients with OLP that had developed 117 malignant neo-
plastic events. With this system, they detected 94.9% 
of the carcinomas at the initial stage (intraepithelial or 
microinvasive) and obtained a 100% survival rate in a 3 
year period and a 96.7% survival rate in a 5 year period, 
suggesting a surveillance protocol of twice a year (18). 
Other authors (13) do not justify the protocols based on 
several visits per year, since on comparing other studies 
with 1, 2 or 4 examinations per year in patients with 
malignant transformation, the number of recurrences 
and deaths was constant regardless of the different pro-
tocols. We conclude in this review on “oral lichenoid 
disease”, that there is a need to study in depth the un-
derstanding of the disease and its different variants, and 
to establish clear diagnostic and therapeutic guidelines 
that would lead us to a reliable prognosis.
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